These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 23128049

  • 1. Renoprotection by continuous erythropoietin receptor activator in puromycin aminonucleoside-induced nephrotic syndrome.
    Aizawa K, Takeda S, Tashiro Y, Yorozu K, Hirata M, Kanada H, Moriguchi Y, Endo K.
    Am J Nephrol; 2012; 36(5):419-26. PubMed ID: 23128049
    [Abstract] [Full Text] [Related]

  • 2. Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression.
    Eto N, Wada T, Inagi R, Takano H, Shimizu A, Kato H, Kurihara H, Kawachi H, Shankland SJ, Fujita T, Nangaku M.
    Kidney Int; 2007 Aug; 72(4):455-63. PubMed ID: 17457371
    [Abstract] [Full Text] [Related]

  • 3. [Differential expressions of miRNAs in kidney in puromycin aminonucleoside nephropathy model and intervened effects of Leizhi capsule].
    Sun W, Li CQ, Chen JH, Shao JD, Zhou D, Zhang L, Gao K.
    Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(1):81-90. PubMed ID: 23596882
    [Abstract] [Full Text] [Related]

  • 4. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
    Shibata S, Nagase M, Fujita T.
    J Am Soc Nephrol; 2006 Mar; 17(3):754-64. PubMed ID: 16452496
    [Abstract] [Full Text] [Related]

  • 5. 1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway.
    Xiao H, Shi W, Liu S, Wang W, Zhang B, Zhang Y, Xu L, Liang X, Liang Y.
    Am J Nephrol; 2009 Mar; 30(1):34-43. PubMed ID: 19202327
    [Abstract] [Full Text] [Related]

  • 6. Nicorandil protects podocytes via modulation of antioxidative capacity in acute puromycin aminonucleoside-induced nephrosis in rats.
    Yamanaka M, Tamura Y, Kuribayashi-Okuma E, Uchida S, Shibata S.
    Am J Physiol Renal Physiol; 2023 Feb 01; 324(2):F168-F178. PubMed ID: 36454699
    [Abstract] [Full Text] [Related]

  • 7. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
    Okada T, Sakaguchi T, Hatamura I, Saji F, Negi S, Otani H, Muragaki Y, Kawachi H, Shigematsu T.
    Clin Exp Nephrol; 2009 Oct 01; 13(5):438-446. PubMed ID: 19452240
    [Abstract] [Full Text] [Related]

  • 8. The effect of low-dose Continuous Erythropoietin receptor activator in an experimental model of acute Cyclosporine A induced renal injury.
    Meerwein C, Korom S, Arni S, Inci I, Weder W, Jungraithmayr W.
    Eur J Pharmacol; 2011 Dec 05; 671(1-3):113-9. PubMed ID: 21968143
    [Abstract] [Full Text] [Related]

  • 9. Erythropoietin ameliorates podocyte injury in advanced diabetic nephropathy in the db/db mouse.
    Loeffler I, Rüster C, Franke S, Liebisch M, Wolf G.
    Am J Physiol Renal Physiol; 2013 Sep 15; 305(6):F911-8. PubMed ID: 23825071
    [Abstract] [Full Text] [Related]

  • 10. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M, Mukoyama M, Mori K, Suganami T, Sawai K, Yoshioka T, Nagae T, Yokoi H, Kawachi H, Shimizu F, Sugawara A, Nakao K.
    J Am Soc Nephrol; 2005 Sep 15; 16(9):2690-701. PubMed ID: 15987752
    [Abstract] [Full Text] [Related]

  • 11. Chinese herbal formula Qilong-Lishui granule improves puromycin aminonucleoside-induced renal injury through regulation of bone morphogenetic proteins.
    Li P, Yan J, Sun Y, Burczynski FJ, Gong Y.
    Nephrology (Carlton); 2007 Oct 15; 12(5):466-73. PubMed ID: 17803470
    [Abstract] [Full Text] [Related]

  • 12. [Bone mesenchymal stem cell transplantation repairs glomerular podocytes in rats with puromycin aminonucleoside-induced nephrosis].
    Yang HD, Dong C, Guan FJ, Gao LL, Zhao T, Feng BF.
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun 15; 12(6):483-7. PubMed ID: 20540862
    [Abstract] [Full Text] [Related]

  • 13. Erythropoietin prevents diabetes-induced podocyte damage.
    Schiffer M, Park JK, Tossidou I, Bartels J, Shushakova N, Menne J, Fliser D.
    Kidney Blood Press Res; 2008 Jun 15; 31(6):411-5. PubMed ID: 19096223
    [Abstract] [Full Text] [Related]

  • 14. Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases.
    Dong N, Meng L, Xue R, Yu M, Zhao Z, Liu X.
    Int Urol Nephrol; 2017 Aug 15; 49(8):1489-1506. PubMed ID: 28528353
    [Abstract] [Full Text] [Related]

  • 15. Podocyte injury is suppressed by 1,25-dihydroxyvitamin D via modulation of transforming growth factor-beta 1/bone morphogenetic protein-7 signalling in puromycin aminonucleoside nephropathy rats.
    Xiao HQ, Shi W, Liu SX, Zhang B, Xu LX, Liang XL, Liang YZ.
    Clin Exp Pharmacol Physiol; 2009 Jul 15; 36(7):682-9. PubMed ID: 19594554
    [Abstract] [Full Text] [Related]

  • 16. Dynamics of absolute amount of nephrin in a single podocyte in puromycin aminonucleoside nephrosis rats calculated by quantitative glomerular proteomics approach with selected reaction monitoring mode.
    Kawakami H, Kamiie J, Yasuno K, Kobayashi R, Aihara N, Shirota K.
    Nephrol Dial Transplant; 2012 Apr 15; 27(4):1324-30. PubMed ID: 21862459
    [Abstract] [Full Text] [Related]

  • 17. Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome.
    Fukuda A, Fujimoto S, Iwatsubo S, Kawachi H, Kitamura K.
    Nephrology (Carlton); 2010 Apr 15; 15(3):321-6. PubMed ID: 20470301
    [Abstract] [Full Text] [Related]

  • 18. Renoprotective effect of the L/N-type calcium channel antagonist cilnidipine on puromycin aminonucleoside-induced nephrosis in rats.
    Takashima K, Nishiyama C, Arisaka N, Takahashi T, Souma S, Tsuda M, Hayashi M, Kasahara H, Kodama H, Tamura T, Murakami M, Kuroda J, Sato F.
    Arzneimittelforschung; 2009 Apr 15; 59(2):79-85. PubMed ID: 19338138
    [Abstract] [Full Text] [Related]

  • 19. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.
    Yamashita J, Nakajima K, Ohno Y, Kaneshiro Y, Matsuo T, Tanaka H, Kaneko K.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):239-44. PubMed ID: 18541230
    [Abstract] [Full Text] [Related]

  • 20. Beneficial effects of orosomucoid on the glomerular barrier in puromycin aminonucleoside-induced nephrosis.
    Hjalmarsson C, Lidell ME, Haraldsson B.
    Nephrol Dial Transplant; 2006 May 28; 21(5):1223-30. PubMed ID: 16410268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.